Archives of Clinical Infectious Diseases

Published by: Kowsar

Correlation of Quantitative Assay of HBsAg and Hepatitis B Virus DNA Levels Among Chronic HBV Patients Attending Pathologist Lancet Laboratory in Nairobi, Kenya

Faith Mathai 1 , 2 , Musa Otieno Ngayo 3 , * , Simon Muturi Karanja 1 , Ahmed Kalebi 2 and Raphael Lihana 4
Authors Information
1 College of Health Sciences, Jomo Kenyatta University of Agriculture and Technology, Nairobi, Kenya
2 Pathology Lancet Kenya, Nairobi, Kenya
3 Centre for Microbiology Research; Kenya Medical Research Institute, Nairobi, Kenya
4 Centre for Virus Research, Kenya Medical Research Institute, Nairobi, Kenya
Article information
  • Archives of Clinical Infectious Diseases: October 2017, 12 (4); e13306
  • Published Online: September 23, 2017
  • Article Type: Research Article
  • Received: November 17, 2016
  • Revised: May 14, 2017
  • Accepted: September 19, 2017
  • DOI: 10.5812/archcid.13306

To Cite: Mathai F, Otieno Ngayo M, Muturi Karanja S, Kalebi A, Lihana R. Correlation of Quantitative Assay of HBsAg and Hepatitis B Virus DNA Levels Among Chronic HBV Patients Attending Pathologist Lancet Laboratory in Nairobi, Kenya, Arch Clin Infect Dis. 2017 ; 12(4):e13306. doi: 10.5812/archcid.13306.

Copyright © 2017, Archives of Clinical Infectious Diseases. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited
1. Background
2. Methods
3. Results
4. Discussion
  • 1. Buster EH, Janssen HL. Antiviral treatment for chronic hepatitis B virus infection--immune modulation or viral suppression?. Neth J Med. 2006;64(6):175-85. [PubMed: 16788215].
  • 2. Feld JJ. HBV treatment in a patient who will be receiving immunosuppressive therapy. Clin Liver Dis. 2013;2(1):34-7. doi: 10.1002/cld.157.
  • 3. World Health Organization . Global hepatitis report 2017, Geneva, world health organization. Geneva: World Health Organization; 2017, [cited 11 May]. Available from:
  • 4. WHO . Hepatitis B 2015. Geneva: World Health Organization, (WHO); 2016, [cited 11 May]. Available from:
  • 5. Muriuki BM, Gicheru MM, Wachira D, Nyamache AK, Khamadi SA. Prevalence of hepatitis B and C viral co-infections among HIV-1 infected individuals in Nairobi, Kenya. BMC Res Notes. 2013;6:363. doi: 10.1186/1756-0500-6-363. [PubMed: 24016453].
  • 6. Kerubo G, Khamadi S, Okoth V, Madise N, Ezeh A, Ziraba A, et al. Hepatitis B, hepatitis C and HIV 1 coinfection in two informal urban settlements in Nairobi, Kenya. PLoS One. 2015;10(6):129247. doi: 10.1371/journal.pone.0129247. [PubMed: 26068212].
  • 7. Jiang W, Liu T, Dong H, Xu Y, Liu LQ, Guan GJ, et al. Relationship Between Serum DNA Replication, Clinicopathological Characteristics and Prognosis of Hepatitis B Virus-associated Glomerulonephritis with Severe Proteinuria by Lamivudine Plus Adefovir Dipivoxil Combination Therapy. Biomed Environ Sci. 2015;28(3):206-13. doi: 10.3967/bes2015.027. [PubMed: 25800445].
  • 8. Mendy ME, Kaye S, van der Sande M, Rayco-Solon P, Waight PA, Shipton D, et al. Application of real-time PCR to quantify hepatitis B virus DNA in chronic carriers in The Gambia. Virol J. 2006;3:23. doi: 10.1186/1743-422X-3-23. [PubMed: 16594999].
  • 9. Ganji A, Esmaeilzadeh A, Ghafarzadegan K, Helalat H, Rafatpanah H, Mokhtarifar A. Correlation between HBsAg quantitative assay results and HBV DNA levels in chronic HBV. Hepat Mon. 2011;11(5):342-5. [PubMed: 22087158].
  • 10. Chan HL, Wong VW, Tse AM, Tse CH, Chim AM, Chan HY, et al. Serum hepatitis B surface antigen quantitation can reflect hepatitis B virus in the liver and predict treatment response. Clin Gastroenterol Hepatol. 2007;5(12):1462-8. doi: 10.1016/j.cgh.2007.09.005. [PubMed: 18054753].
  • 11. Togo S, Arai M, Tawada A, Chiba T, Kanda T, Fujiwara K, et al. Clinical importance of serum hepatitis B surface antigen levels in chronic hepatitis B. J Viral Hepat. 2011;18(10):508-15. doi: 10.1111/j.1365-2893.2011.01486.x. [PubMed: 21914070].
  • 12. Demiroren K, Kocamaz H, Dogan Y. The importance of the serum quantitative levels of hepatitis B surface antigen and hepatitis B e antigen in children with chronic hepatitis B. Turk J Gastroenterol. 2015;26(1):36-41. doi: 10.5152/tjg.2015.4636. [PubMed: 25698269].
  • 13. Arai M, Togo S, Kanda T, Fujiwara K, Imazeki F, Yokosuka O. Quantification of hepatitis B surface antigen can help predict spontaneous hepatitis B surface antigen seroclearance. Eur J Gastroenterol Hepatol. 2012;24(4):414-8. doi: 10.1097/MEG.0b013e328350594d. [PubMed: 22273987].
  • 14. Chan HL, Wong GL, Chim AM, Chan HY, Chu SH, Wong VW. Prediction of off-treatment response to lamivudine by serum hepatitis B surface antigen quantification in hepatitis B e antigen-negative patients. Antivir Ther. 2011;16(8):1249-57. doi: 10.3851/IMP1921. [PubMed: 22155906].
  • 15. Lemeshow S, Hosmer DW, Klar J, Lwanga SK. World health organization, adequacy of sample size in health studies. Chichester, England: Published on behalf of the World Health Organization by John Wiley and Sons; 1990.
  • 16. Park Y, Hong DJ, Shin S, Cho Y, Kim HS. Performance evaluation of new automated hepatitis B viral markers in the clinical laboratory: two quantitative hepatitis B surface antigen assays and an HBV core-related antigen assay. Am J Clin Pathol. 2012;137(5):770-7. doi: 10.1309/AJCP8QDN7NAUXJFJ. [PubMed: 22523216].
  • 17. Zhou R, Pan F, Lin C, Lin X, Gao H, Huang S, et al. Baseline prognostic factors and statistic model to predict early virological response in lamivudine-treated patients with chronic hepatitis B. Int J Clin Exp Med. 2015;8(10):19258-65. [PubMed: 26770562].
  • 18. Schweitzer A, Horn J, Mikolajczyk RT, Krause G, Ott JJ. Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013. Lancet. 2015;386(10003):1546-55. doi: 10.1016/s0140-6736(15)61412-x.
  • 19. Maylin S, Sire JM, Mbaye PS, Simon F, Sarr A, Evra ML, et al. Short-term spontaneous fluctuations of HBV DNA levels in a Senegalese population with chronic hepatitis B. BMC Infect Dis. 2015;15:154. doi: 10.1186/s12879-015-0881-4. [PubMed: 25887383].
  • 20. Zhu HY, Zhang XS. Relationship between HBV DNA load and levels of serum HBsAg in patients with chronic hepatitis B. Eur Rev Med Pharmacol Sci. 2016;20(10):2061-4. [PubMed: 27249605].
  • 21. Seth AK. HBsAg Quantification in Clinical Practice. J Clin Exp Hepatol. 2012;2(1):75-80. doi: 10.1016/S0973-6883(12)60084-X. [PubMed: 25755408].
  • 22. Gunal O, Barut S, Etikan I, Duygu F, Tuncel U, Sunbul M. Relation between serum quantitative HBsAg, ALT and HBV DNA levels in HBeAg negative chronic HBV infection. Turk J Gastroenterol. 2014;25 Suppl 1:142-6. doi: 10.5152/tjg.2014.5711. [PubMed: 25910293].
  • 23. Martinot-Peignoux M, Lapalus M, Asselah T, Marcellin P. The role of HBsAg quantification for monitoring natural history and treatment outcome. Liver Int. 2013;33 Suppl 1:125-32. doi: 10.1111/liv.12075. [PubMed: 23286856].
  • 24. Tsai WL, Sun WC, Cheng JS. Chronic Hepatitis B with Spontaneous Severe Acute Exacerbation. Int J Mol Sci. 2015;16(12):28126-45. doi: 10.3390/ijms161226087. [PubMed: 26703566].
  • 25. Mahdavi MR, Haghshenas MR, Roshan P, Hojjati MT, Mahdavi M, Jalali H. Is quantitative HBsAg measurement a reliable substitute for HBV DNA quantitation?. Res Mol Med. 2015;3(3):33-7. doi: 10.7508/rmm.2015.03.007.
  • 26. Kim YJ, Cho HC, Choi MS, Lee JH, Koh KC, Yoo BC, et al. The change of the quantitative HBsAg level during the natural course of chronic hepatitis B. Liver Int. 2011;31(6):817-23. doi: 10.1111/j.1478-3231.2011.02516.x. [PubMed: 21645212].
  • 27. Teriaky A, Al-Judaibi B. Correlation between HBsAg quantitation and HBV DNA in HBeAg-negative HBV/D patients. Saudi J Gastroenterol. 2013;19(6):243-4. doi: 10.4103/1319-3767.121030. [PubMed: 24195976].
  • 28. Jaroszewicz J, Calle Serrano B, Wursthorn K, Deterding K, Schlue J, Raupach R, et al. Hepatitis B surface antigen (HBsAg) levels in the natural history of hepatitis B virus (HBV)-infection: a European perspective. J Hepatol. 2010;52(4):514-22. doi: 10.1016/j.jhep.2010.01.014. [PubMed: 20207438].
  • 29. Coskun BD, Altinkaya E, Sevinc E, Ozen M, Karaman H, Karaman A, et al. The diagnostic value of a globulin/platelet model for evaluating liver fibrosis in chronic hepatitis B patients. Rev Esp Enferm Dig. 2015;107(12):740-4. [PubMed: 26671586].
  • 30. Wang M, Qiu N, Lu S, Xiu D, Yu J, Wang XT, et al. Serum hepatitis B surface antigen is correlated with intrahepatic total HBV DNA and cccDNA in treatment-naive patients with chronic hepatitis B but not in patients with HBV related hepatocellular carcinoma. J Med Virol. 2013;85(2):219-27. doi: 10.1002/jmv.23461. [PubMed: 23168998].

Featured Image:

Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments